Bortezomib-Melphalan Conditioning Regimen vs Melphalan for Frontline Transplant Eligible Patients With Multiple Myeloma
Clinical trial NCT02197221 · COMPLETED
Trial details
- NCT number
- NCT02197221
- Sponsor
- University Hospital, Toulouse
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-01-01
- Primary completion
- 2018-12-31
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.